Liver Cancer Treatment Landscape Shifts Rapidly, but Best Sequencing Still Unclear

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — Immunotherapy-based combinations have quickly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but actual results remain severely limited by liver function and the burden of comorbidities…



